JPRN-UMIN000042892招募中2 期
Efficacy and safety of irinotecan after chemotherapy in combination with immunotherapy in patients with extensive stage small cell lung cancer: a phase II trial - Efficacy and safety of irinotecan after chemotherapy in combination with immunotherapy in patients with extensive stage small cell lung cancer: a phase II trial
Third department of internal medicine, Universtiy of Fukui0 个研究点目标入组 22 人开始时间: 2021年1月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who previously treated with irinotecan 2) Patients with homozygous polymorphisms for UGT1A1*28 and *6 (*28/*28, *6/*6, and *6/*28) 3) Diarrhea (grade 1 or more) before the treatment. 4) Uncontrolable pleural or pericardial effusion. 5) Within 2 weeks after radiotherapy. 6) Operation within 4 weeks. 7) Active double cancer. 8) Active infectious disease. 9) Severe complications including heart failure, hepatic failure, renal failure, paresis of intestine, and ileus. 10) Pregnant woman. 11) HBs antigen positive. 12) Patients who received systemic corticosteroid (10mg or more prednisolone conversion). 13) The subjects whom the doctor excluded.
研究者
相似试验
已完成
2 期
Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma.angiosarcomaJPRN-UMIN000008187ational Cancer Center Hospital18
招募中
2 期
Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma. The ANGIRI study.AngiosarcomaJPRN-UMIN000002805Masashi Ando18
已完成
1 期
A phase I/II study of chemotherapy using Irinotecan, S-1 plus Oxaliplatin (IRISOX therapy) for unresectable pancreatic cancerJPRN-UMIN000016945Department of Gastroenterology Kitasato University School of Medicine25
已完成
不适用
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervixstage 1b2/2 cervical cancerJPRN-UMIN000000552Japanese Gynecologic Oncology Group65
已完成
不适用
Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancerJPRN-UMIN000011993ational Defense Medical College49